PUK17 Economic Benefits of Slowing Progress to End Stage Renal Disease (ESRD) in Patients with Diabetes-Related Chronic Kidney Disease (DKD), Compared with Standard of Care (SOC)
Abstract
Authors
L.J. Smolen T.M. Klein J.R. Voelker J. Sierra-johnson M.E. Boye